|
業務類別
|
Diagnostics & Research |
|
業務概覽
|
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests. |
| 公司地址
| 1500 West Parkwood Avenue, Suite 401, Friendswood, TX, USA, 77546 |
| 電話號碼
| +1 866 788-9007 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.castlebiosciences.com |
| 員工數量
| 883 |
| Mr. Frank Stokes |
Chief Financial Officer and Principal Accounting Officer |
美元 500.04K |
26/02/2026 |
| Ms. Kristen M. Oelschlager |
Chief Operating Officer |
美元 506.42K |
09/04/2025 |
| Mr. Tobin W. Juvenal |
Chief Commercial Officer |
美元 506.42K |
09/04/2025 |
| Mr. Derek J. Maetzold |
Director, President and Chief Executive Officer |
美元 715.57K |
26/02/2026 |
|
|
| Mr. Rodney Cotton |
Independent Director |
26/02/2026 |
| Mr. Daniel M. Bradbury |
Chairman of the Board |
26/02/2026 |
| Mr. G. Bradley Cole |
Independent Director |
26/02/2026 |
| Ms. Tiffany P. Olson |
Independent Director |
26/02/2026 |
| Mr. Miles D. Harrison |
Independent Director |
26/02/2026 |
| Mr. Derek J. Maetzold |
Director, President and Chief Executive Officer |
26/02/2026 |
| Ms. Kimberlee S. Caple |
Independent Director |
26/02/2026 |
| Ms. Ellen Goldberg |
Independent Director |
26/02/2026 |
|
|
|
|
